Day: September 14, 2020

DENVER, Sept. 14, 2020 (GLOBE NEWSWIRE) — Black Hills Corp.’s (NYSE: BKH) Colorado natural gas utility, Black Hills Colorado Gas, Inc., doing business as Black Hills Energy, on Friday, Sept. 11, filed a rate review application with the Colorado Public Utilities Commission requesting $13.5 million in new annual revenue to recover the investments made in its natural-gas infrastructure to serve customers. In a separate filing, as required by the Colorado commission, the company is also proposing a five-year system safety and integrity rider to recover the investment cost of maintaining the safety and integrity of the natural gas system.From July 2018 through year-end 2020, Colorado Gas will have invested over $105 million in replacing, upgrading and expanding its natural gas system in the state. The 7,000 miles of natural gas transmission...

MOORESTOWN, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces today that Medplus Solutions, a pharmacy services provider in Puerto Rico, will deploy MedWise™ medication safety solutions for their long-term care clients. Additionally, Medplus will enhance their clinical pharmacy services by certifying their pharmacists as MedWise Advisors™.“As the only dedicated and accredited long-term care pharmacy in Puerto Rico, we understand how vital medication safety is for chronically-ill patients on multiple medications,” states Sultan S. Yassin, PharmD, President and CEO of Medplus. “MedWise will allow us to identify simultaneous multi-drug interactions and will facilitate interventions by our pharmacists to...

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.comNEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) — Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, September 17th with the first live webcast at 9:30 AM ET.REGISTER NOW AT: https://bit.ly/3m5MTfYIt is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost...

EDMONTON, Alberta, Sept. 14, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles Gagnon, President and Chief Executive Officer of Ceapro will present at the H.C. Wainwright 22ndAnnual Global Investment Conference on Wednesday, September 16, 2020 at 3:30 PM EDT.In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information, please visit the conference website here.A live video webcast of the presentation will be available on the IR Calendar page of the Investors...

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.comNEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) — Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, September 17th with the first live webcast at 9:30 AM ET.REGISTER NOW AT: https://bit.ly/3m5MTfYIt is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost...

Albion Technology & General VCT PLCLEI number: 213800TKJUY376H3KN16As required by the UK Listing Authority’s Disclosure Guidance and Transparency Rule 4.2, Albion Technology & General VCT PLC today makes public its information relating to the Half-yearly Financial Report (which is unaudited) for the six months to 30 June 2020. This announcement was approved by the Board of Directors on 14 September 2020.The full Half-yearly Financial Report (which is unaudited) for the period to 30 June 2020, will shortly be sent to shareholders. Copies of the full Half-yearly Financial Report will be shown via the Albion Capital Group LLP website by clicking www.albion.capital/funds/AATG/30Jun20.pdf.Investment objective and policyThe Company’s investment objective is to provide investors with a regular and predictable source of dividend...

HOUSTON, Sept. 14, 2020 (GLOBE NEWSWIRE) — Apache Corporation (Nasdaq: APA) and Total S.A. (NYSE: TOT) today provided an update to the technical evaluation of the Kwaskwasi-1 discovery well offshore Suriname.As previously announced, Kwaskwasi-1 discovered hydrocarbons in multiple stacked targets in the upper Cretaceous-aged Campanian and Santonian intervals. The well encountered 278 meters (912 feet) of net oil and volatile oil/gas condensate pay. The shallower Campanian interval contains 63 meters (207 feet) of net oil pay and 86 meters (282 feet) of net volatile oil/gas condensate pay. The Santonian interval contains 129 meters (423 feet) of net pay. Fluid samples from the Campanian validated the presence of oil with API gravities between 34 and 43 degrees.Since the discovery announcement on July 29, 2020, the Noble Sam Croft...

HOUSTON, Sept. 14, 2020 (GLOBE NEWSWIRE) — C-Bond Systems, Inc., (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has paid off all of its remaining discounted convertible debt and strengthened its balance sheet.The Company repaid its last two convertible promissory notes held by a third-party lender, which were convertible into the Company’s common stock at a discount to the market price.“I am proud that we have been able to achieve our goal of eliminating all discounted convertible debt, thereby strengthening our balance sheet and minimizing potential dilution for shareholders,” said Scott R. Silverman, Chairman and Chief Executive Officer of C-Bond Systems.  “Concurrent with this milestone, our underlying business continues to expand, and we are seeing positive signs of growth...

WILMETTE, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced that Chandler D. Robinson, MD, Chief Executive Officer, will present a corporate update at the H.C. Wainwright 22nd Annual Global Investment Conference, Healthcare & Biotech Track. The conference will be held virtually.Presentation Details:Date: Wednesday, September 16, 2020Time: 1:30 PM EDTLocation: Virtualhttps://hcwevents.com/For more information, please contact investor relations at kimtsu@monopartx.com.About Monopar Therapeutics Inc. Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar’s pipeline consists of Validive® for the prevention of chemoradiotherapy-induced...

Relugolix combination therapy maintained bone mineral density through one year, consistent with bone mineral density changes observed in untreated womenFindings presented at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting Virtual EventBASEL, Switzerland, Sept. 14, 2020 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced the presentation of one-year data on bone mineral density (BMD) from the Phase 3 LIBERTY program evaluating the safety and efficacy of once-daily relugolix combination therapy (relugolix 40 mg plus estradiol 1.0 mg and norethindrone acetate 0.5 mg) in women with uterine fibroids. The BMD results from the LIBERTY program demonstrated maintenance of BMD through one year and were consistent with those...